Technimark Acquires Medical Molder Ci Medical Technologies

Technimark, a leading global manufacturer of custom rigid packaging, consumer healthcare, and medical solutions, announced today that it has acquired Ci Medical Technologies from Altaris Capital Partners. Purchase price was not disclosed.
 
Ci Medical is a top manufacturer of injection-molded components, assemblies and devices used in the medical, pharmaceutical and consumer healthcare markets. As part of the acquisition, Technimark will establish a new commercial division, Technimark Healthcare, focused on servicing Healthcare and Medical customers.
 
Technimark’s acquisition of Ci Medical will expand the manufacturing capabilities and global footprint for customers of both companies. The combined company will leverage Technimark’s culture of product innovation and technical excellence with Ci Medical’s scientific and healthcare manufacturing expertise. The combined company will have 11 sites throughout the world including the United States, Germany, Mexico, China, Puerto Rico, and the United Kingdom.
 
Ci Medical specializes in product development, scientific molding, contract manufacturing, assembly, packaging, and logistics, with a focus on cost effectiveness and quality for the medical industry. Operations at Ci Medical meet applicable ANSI and ISO standards and FDA regulations for the manufacture of its medical products, including insulin pumps, surgical tools, and other specialized devices. These proficiencies complement Technimark’s parallel development of a robust healthcare manufacturing infrastructure, including class 8 clean rooms and ISO 13485 certifications.
 
“The acquisition of Ci Medical accelerates Technimark’s growth in the healthcare and medical markets,” said Brad Wellington, CEO of Technimark.

Kris Peavy, SVP of sales for Technimark, added, “By combining Technimark’s innovative technology-based offering, strong balance sheet and global scale with Ci’s medical market experience, infrastructure and operational capabilities across a wide range of pharmaceutical and medical products, we are uniquely positioned to offer our customers more value than ever before.”